VIVE News and Press, Viveve Medical Inc. From 07/12/22

Medical technology company Viveve Medical ( NASDAQ: VIVE ) received a patent for the company's dual-energy technology by the Taiwan Intellectual Property Office. The Taiwan Patent No. I766557 further expands and strengthens VIVE's intellectual property portfolio in the&#x...

ENGLEWOOD, CO / ACCESSWIRE / May 17, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's health, today announced that Scott Durbin, chief executive officer, will participate in the H.C. Wainwright Global Investment Conference, May 23 - 26, 2022. Mr. Dur...

Durbin recognized for second consecutive year for leading development of Viveve's innovative technology for treatment of stress urinary incontinence in women ENGLEWOOD, CO / ACCESSWIRE / May 17, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's i...

Viveve Medical, Inc. (VIVE) Q1 2022 Earnings Conference Call May 12, 2022 05:00 PM ET Company Participants Jeannie Swindle - Senior Director, Corporate Communications Jim Robbins - Senior Vice President, Finance and Administration Scott Durbin - Chief Executive Officer Conference Call Partici...

Viveve Medical press release (NASDAQ:VIVE): Q1 GAAP EPS of -$0.67 beats by $0.01. Revenue of $1.64M (+13.1% Y/Y) beats by $0.03M. Increased the installed base of Viveve Systems to 895 systems worldwide. Cash and cash equivalents were $14.0 million as of March 31, 2022, compared to $19.2 ...

Total revenue of $1.6 million in Q1 including sale of 2,750 consumable treatment tips PURSUIT trial top-line results anticipated at end of 2022 Conference call to be hosted by Company at 5:00 PM ET today ENGLEWOOD, CO / ACCESSWIRE / May 12, 2022 / Viveve Medical, Inc. (NASDA...

ENGLEWOOD, CO / ACCESSWIRE / April 28, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that it will report its first quarter 2022 financial results and provide a corporate update after the close of the U.S. financial...

Viveve Medical Inc. (VIVE) Q4 2021 Earnings Conference Call March 17, 2022 5:00 PM ET Company Participants Jeannie Swindle - Senior Director of Corporate Communications Scott Durbin - CEO and Director Jim Robbins - SVP, Finance and Administration Presentation Operator Good afternoon, and welc...

Viveve Medical press release (NASDAQ:VIVE): FY GAAP EPS of -$2.65 misses by $0.13. Revenue of $6.43M (+17.3% Y/Y) beats by $0.01M. Shares -1.99%. For further details see: Viveve Medical GAAP EPS of -$2.65 misses by $0.13, revenue of $6.43M beats by $0.01M

Reported total revenue for year end 2021 of $6.4 million representing 17% year-over-year growth Enrollment completed in U.S. pivotal PURSUIT trial for stress urinary incontinence and 12-month post treatment follow-up visits underway PURSUIT top-line results anticipated at end of 20...